Developers of pharmacogenetic tests cheered in August when United Healthcare (UHC) concluded in a policy statement effective October 1, that “the use of pharmacogenetic multi-gene panels to guide ...

OXFORD, England--(BUSINESS WIRE)--Diffblue, creators of the world’s first fully-autonomous AI agent for unit testing, today released Test Review, a new feature that allows developers to edit, analyze, ...

Brandy Guarda, Regulatory Analyst in Washington, D.C., contributed to the drafting of this post. For in vitro diagnostic test developers, the monkeypox public health emergency presents an urgent ...

Talis Biomedical, which is developing diagnostic tests for COVID-19 and other infectious diseases, raised the proposed deal size for its upcoming IPO on Thursday. The Menlo Park, CA-based company now ...

Early is a Tel Aviv-based startup that uses generative AI to generate unit tests, helping programmers catch potential bugs early in the development cycle. The company, which launched in August, today ...

A new guidance from the US Food and Drug Administration (FDA) provides considerations for developers of molecular, antigen and serology COVID-19 tests as they evaluate how viral mutations may affect ...

The COVID-19 pandemic has highlighted the need for reliable diagnostic tests for the new SARS-CoV-2 virus, and treatments that can cure or mitigate its devastating effects. To have an impact, these ...

Talis Biomedical, which is developing diagnostic tests for COVID-19 and other infectious diseases, announced terms for its IPO on Monday. The Menlo Park, CA-based company plans to raise $150 million ...

Value stream management involves people in the organization to examine workflows and other processes to ensure they are deriving the maximum value from their efforts while eliminating waste — of ...